HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study. [electronic resource]
- HIV clinical trials 05 2017
- 126-134 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1945-5771
10.1080/15284336.2017.1330801 doi
Antiviral Agents--therapeutic use Female HIV Infections--drug therapy Hepatitis C, Chronic--complications Humans Male Middle Aged Prospective Studies Spain Sustained Virologic Response Treatment Outcome